Healthcare provider profile · identity verified

Debbra A Mcglaughlin, FNP

Nurse Practitioner · MADAWASKA, ME · NPI 1922030527

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	394	98
Atorvastatin Calcium	Atorvastatin Calcium	343	115
Lisinopril	Lisinopril	304	96
Metoprolol Succinate	Metoprolol Succinate	263	82
Simvastatin	Simvastatin	238	77
Pantoprazole Sodium	Pantoprazole Sodium	221	80
Amlodipine Besylate	Amlodipine Besylate	200	66
Losartan Potassium	Losartan Potassium	173	55
Atenolol	Atenolol	171	52
Albuterol Sulfate Hfa	Albuterol Sulfate	163	56
Omeprazole	Omeprazole	153	41
Metformin Hcl	Metformin Hcl	141	51
Sertraline Hcl	Sertraline Hcl	130	42
Trazodone Hcl	Trazodone Hcl	125	44
Hydrochlorothiazide	Hydrochlorothiazide	114	40
Furosemide	Furosemide	110	49
Tamsulosin Hcl	Tamsulosin Hcl	110	39
Eliquis	Apixaban	107	30
Prednisone	Prednisone	103	59
Rosuvastatin Calcium	Rosuvastatin Calcium	102	34
Gabapentin	Gabapentin	96	40
Escitalopram Oxalate	Escitalopram Oxalate	88	20
Metoprolol Tartrate	Metoprolol Tartrate	84	31
Citalopram Hbr	Citalopram Hydrobromide	72	18
Warfarin Sodium	Warfarin Sodium	64	14
Duloxetine Hcl	Duloxetine Hcl	60	16
Alprazolam	Alprazolam	58	22
Potassium Chloride	Potassium Chloride	57	17
Famotidine	Famotidine	55	20
Finasteride	Finasteride	54	14
Fluticasone Propionate	Fluticasone Propionate	53	18
Ozempic	Semaglutide	53	11
Pravastatin Sodium	Pravastatin Sodium	52	17
Buspirone Hcl	Buspirone Hcl	49	19
Memantine Hcl	Memantine Hcl	48	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	31
Lidocaine Hcl Viscous	Lidocaine Hcl	47	suppressed
Bupropion Xl	Bupropion Hcl	46	13
Clonazepam	Clonazepam	46	suppressed
Methylprednisolone	Methylprednisolone	46	37
Doxycycline Hyclate	Doxycycline Hyclate	45	38
Breo Ellipta	Fluticasone/Vilanterol	44	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	11
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Meclizine Hcl	Meclizine Hcl	40	15
Tramadol Hcl	Tramadol Hcl	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Azithromycin	Azithromycin	37	32
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	12
Clotrimazole	Clotrimazole	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	11
Allopurinol	Allopurinol	32	13
Hydroxyzine Pamoate	Hydroxyzine Pamoate	32	15
Lovastatin	Lovastatin	32	13
Amoxicillin	Amoxicillin	31	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	20
Ezetimibe	Ezetimibe	31	11
Lorazepam	Lorazepam	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	19
Nystatin	Nystatin	30	25
Oxybutynin Chloride	Oxybutynin Chloride	30	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Spironolactone	Spironolactone	29	12
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Jardiance	Empagliflozin	27	11
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Fluconazole	Fluconazole	25	19
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Glipizide	Glipizide	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Meloxicam	Meloxicam	22	11
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Temazepam	Temazepam	22	suppressed
Lidocaine	Lidocaine	21	suppressed
Estradiol	Estradiol	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	11
Entresto	Sacubitril/Valsartan	18	suppressed
Nitroglycerin	Nitroglycerin	18	12
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	17	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Cephalexin	Cephalexin	16	14
Diazepam	Diazepam	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error